Beth Wilmot1, Rebecca Fry2, Lisa Smeester2, Erica D Musser3, Jonathan Mill4,5, Joel T Nigg1. 1. Division of Psychology, Oregon Health & Science University, Portland, OR, USA. 2. Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA. 3. Department of Psychology, Florida International University, Miami, FL, USA. 4. University of Exeter Medical School, Exeter University, Exeter, UK. 5. Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Abstract
BACKGROUND: Peripheral epigenetic marks hold promise for understanding psychiatric illness and may represent fingerprints of gene-environment interactions. We conducted an initial examination of CpG methylation variation in children with or without attention-deficit/hyperactivity disorder (ADHD). METHODS: Children age 7-12 were recruited, screened, evaluated and assigned to ADHD or non-ADHD groups by defined research criteria. Two independent age-matched samples were examined, a discovery set (n = 92, all boys, half control, half ADHD) and a confirmation set (n = 20, half ADHD, all boys). 5-methylcytosine levels were quantified in salivary DNA using the Illumina 450 K HumanMethylation array. Genes for which multiple probes were nominally significant and had a beta difference of at least 2% were evaluated for biological relevance and prioritized for confirmation and sequence validation. Gene pathways were explored and described. RESULTS: Two genes met the criteria for confirmation testing, VIPR2 and MYT1L; both had multiple probes meeting cutoffs and strong biological relevance. Probes on VIPR2 passed FDR correction in the confirmation set and were confirmed through bisulfite sequencing. Enrichment analysis suggested involvement of gene sets or pathways related to inflammatory processes and modulation of monoamine and cholinergic neurotransmission. CONCLUSIONS: Although it is unknown to what extent CpG methylation seen in peripheral tissue reflect transcriptomic changes in the brain, these initial results indicate that peripheral DNA methylation markers in ADHD may be promising and suggest targeted hypotheses for future study in larger samples.
BACKGROUND: Peripheral epigenetic marks hold promise for understanding psychiatric illness and may represent fingerprints of gene-environment interactions. We conducted an initial examination of CpG methylation variation in children with or without attention-deficit/hyperactivity disorder (ADHD). METHODS:Children age 7-12 were recruited, screened, evaluated and assigned to ADHD or non-ADHD groups by defined research criteria. Two independent age-matched samples were examined, a discovery set (n = 92, all boys, half control, half ADHD) and a confirmation set (n = 20, half ADHD, all boys). 5-methylcytosine levels were quantified in salivary DNA using the Illumina 450 K HumanMethylation array. Genes for which multiple probes were nominally significant and had a beta difference of at least 2% were evaluated for biological relevance and prioritized for confirmation and sequence validation. Gene pathways were explored and described. RESULTS: Two genes met the criteria for confirmation testing, VIPR2 and MYT1L; both had multiple probes meeting cutoffs and strong biological relevance. Probes on VIPR2 passed FDR correction in the confirmation set and were confirmed through bisulfite sequencing. Enrichment analysis suggested involvement of gene sets or pathways related to inflammatory processes and modulation of monoamine and cholinergic neurotransmission. CONCLUSIONS: Although it is unknown to what extent CpG methylation seen in peripheral tissue reflect transcriptomic changes in the brain, these initial results indicate that peripheral DNA methylation markers in ADHD may be promising and suggest targeted hypotheses for future study in larger samples.
Authors: Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth Journal: Nucleic Acids Res Date: 2015-01-20 Impact factor: 16.971
Authors: Matthew N Davies; Manuela Volta; Ruth Pidsley; Katie Lunnon; Abhishek Dixit; Simon Lovestone; Cristian Coarfa; R Alan Harris; Aleksandar Milosavljevic; Claire Troakes; Safa Al-Sarraj; Richard Dobson; Leonard C Schalkwyk; Jonathan Mill Journal: Genome Biol Date: 2012-06-15 Impact factor: 13.583
Authors: Jennie Garcia-Olivares; Delany Torres-Salazar; William A Owens; Tracy Baust; David P Siderovski; Susan G Amara; Jun Zhu; Lynette C Daws; Gonzalo E Torres Journal: PLoS One Date: 2013-03-26 Impact factor: 3.240
Authors: Jenny van Dongen; Nuno R Zilhão; Karen Sugden; Eilis J Hannon; Jonathan Mill; Avshalom Caspi; Jessica Agnew-Blais; Louise Arseneault; David L Corcoran; Terrie E Moffitt; Richie Poulton; Barbara Franke; Dorret I Boomsma Journal: Biol Psychiatry Date: 2019-03-01 Impact factor: 13.382
Authors: Eric J Chater-Diehl; Benjamin I Laufer; Christina A Castellani; Bonnie L Alberry; Shiva M Singh Journal: PLoS One Date: 2016-05-02 Impact factor: 3.240
Authors: R Hammamieh; N Chakraborty; A Gautam; S Muhie; R Yang; D Donohue; R Kumar; B J Daigle; Y Zhang; D A Amara; S-A Miller; S Srinivasan; J Flory; R Yehuda; L Petzold; O M Wolkowitz; S H Mellon; L Hood; F J Doyle; C Marmar; M Jett Journal: Transl Psychiatry Date: 2017-07-11 Impact factor: 6.222
Authors: Gemma C Sharp; Lucas A Salas; Claire Monnereau; Catherine Allard; Paul Yousefi; Todd M Everson; Jon Bohlin; Zongli Xu; Rae-Chi Huang; Sarah E Reese; Cheng-Jian Xu; Nour Baïz; Cathrine Hoyo; Golareh Agha; Ritu Roy; John W Holloway; Akram Ghantous; Simon K Merid; Kelly M Bakulski; Leanne K Küpers; Hongmei Zhang; Rebecca C Richmond; Christian M Page; Liesbeth Duijts; Rolv T Lie; Phillip E Melton; Judith M Vonk; Ellen A Nohr; ClarLynda Williams-DeVane; Karen Huen; Sheryl L Rifas-Shiman; Carlos Ruiz-Arenas; Semira Gonseth; Faisal I Rezwan; Zdenko Herceg; Sandra Ekström; Lisa Croen; Fahimeh Falahi; Patrice Perron; Margaret R Karagas; Bilal M Quraishi; Matthew Suderman; Maria C Magnus; Vincent W V Jaddoe; Jack A Taylor; Denise Anderson; Shanshan Zhao; Henriette A Smit; Michele J Josey; Asa Bradman; Andrea A Baccarelli; Mariona Bustamante; Siri E Håberg; Göran Pershagen; Irva Hertz-Picciotto; Craig Newschaffer; Eva Corpeleijn; Luigi Bouchard; Debbie A Lawlor; Rachel L Maguire; Lisa F Barcellos; George Davey Smith; Brenda Eskenazi; Wilfried Karmaus; Carmen J Marsit; Marie-France Hivert; Harold Snieder; M Daniele Fallin; Erik Melén; Monica C Munthe-Kaas; Hasan Arshad; Joseph L Wiemels; Isabella Annesi-Maesano; Martine Vrijheid; Emily Oken; Nina Holland; Susan K Murphy; Thorkild I A Sørensen; Gerard H Koppelman; John P Newnham; Allen J Wilcox; Wenche Nystad; Stephanie J London; Janine F Felix; Caroline L Relton Journal: Hum Mol Genet Date: 2017-10-15 Impact factor: 6.150